Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1285-1296 of 2022 results
Page 108 of 169
Key Publications February 21, 2014

Interplay of pro- and anti-inflammatory cytokines to determine lipid accretion in adipocytes.

Int J Obes (Lond) 2013;37:1490-8

Wang Y, Wang H, Hegde V, Dubuisson O, Gao Z, Dhurandhar NV, Ye J.
Adipose Tissue Inflammation Lipids/Lipoproteins
Key Publications February 21, 2014

High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

J Lipid Res 2013;54:3227-43

Riwanto M, Landmesser U
Lipids/Lipoproteins Metabolism: Human Studies
Key Publications February 20, 2014

Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids).

J Am Coll Cardiol 2013;62:1960-5

Elshazly MB, Martin SS, Blaha MJ, Joshi PH, Toth PP, McEvoy JW, Al-Hijji MA, Kulkarni KR, Kwiterovich PO, Blumenthal RS, Jones SR.
Epidemiology Lipids/Lipoproteins
Key Publications February 17, 2014

High-density lipoprotein and residual cardiovascular risk: De minimis non curat medicus or the COURAGE to be SMART?

J Am Coll Cardiol 2013;62:1842-4

Genest J
Lipids/Lipoproteins
Key Publications February 14, 2014

Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

J Am Coll Cardiol 2013;62:1826-33

Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ, Sedlis SP, Kostuk W, Spertus JA, Dada M, Chaitman BR, Mancini GB, Weintraub WS
Lipids/Lipoproteins
Key Publications February 14, 2014

Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.

J Am Coll Cardiol 2013;62:1834-41

van de Woestijne AP, van der Graaf Y, Liem AH, Cramer MJ, Westerink J, Visseren FL, SMART Study Group
Lipids/Lipoproteins Prevention
Key Publications February 12, 2014

Relation of hepatic steatosis to atherogenic dyslipidemia.

Am J Cardiol 2013;112:1599-604

Makadia SS, Blaha M, Keenan T, Ndumele C, Jones S, DeFilippis A, Martin S, Kohli P, Conceicao R, Carvalho J, Nasir K, Blumenthal R,Santos RD
Ectopic Fat Lipids/Lipoproteins Metabolic Syndrome
Key Publications February 12, 2014

Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.

Eur Heart J 2013;34:3182-90

Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ
Lipids/Lipoproteins
Key Publications February 5, 2014

Untrained young men have dysfunctional HDL compared with strength-trained men irrespective of body weight status.

J Appl Physiol (1985) 2013;115:1043-9

Roberts CK, Katiraie M, Croymans DM, Yang OO, Kelesidis T
Lipids/Lipoproteins Obesity Physical Activity/Exercise
Key Publications February 4, 2014

Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.

J Clin Endocrinol Metab 2013;98:3989-98

Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, Arakaki R, Watson K, Horton E, Barrett-Connor E
Diabetes Lipids/Lipoproteins Physical Activity/Exercise
Key Publications February 4, 2014

Demystifying the management of hypertriglyceridaemia.

Nat Rev Cardiol 2013;10:648-61

Watts GF, Ooi EM, Chan DC
Genetics Lipids/Lipoproteins Nutrition
Key Publications January 28, 2014

Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).

J Am Coll Cardiol 2013;62:1580-4

Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, Marcovina SM, Nash SD, O'Brien KD, Weintraub WS, Xu P,Zhao XQ, Boden WE
Lipids/Lipoproteins Metabolic Syndrome
of 169